TLDR
- Shares of Rocket Lab (RKLB) rose 10.2% during Tuesday’s session, settling at $78.59 for the third consecutive day of upward movement.
- The surge followed confirmation of two Electron rocket missions scheduled within days of one another.
- Approximately 28.4 million shares traded hands — about 33% higher than typical daily activity.
- Bank of America maintains a bullish $120 price target on RKLB shares, significantly exceeding the Street’s consensus of $75.92.
- Company insiders have divested roughly $139 million in shares during the previous three-month period, while institutional ownership remains at approximately 71.8%.
Shares of Rocket Lab experienced a 10.2% advance on Tuesday, finishing the session at $78.59. The upward movement followed the company’s confirmation of two forthcoming Electron rocket missions.
The previous trading session saw RKLB close at $71.31, with Tuesday’s gain representing the third consecutive positive day for the stock.
Trading activity was notably elevated: approximately 28.4 million shares exchanged ownership throughout the day — representing a 33% increase compared to the typical daily volume of 21.3 million units.
The aerospace company revealed plans for its 84th Electron mission, dubbed “Eight Days A Week,” scheduled for no later than Friday, March 20. This flight will deploy a synthetic aperture radar satellite to low Earth orbit (LEO) as part of Synspective’s StriX constellation.
Following closely behind, the 85th Electron mission titled “Daughter of the Stars” has a launch window extending through Tuesday, March 24. This launch represents Rocket Lab’s inaugural mission for the European Space Agency (ESA), carrying two Pathfinder A satellites designed to validate a novel LEO satellite navigation system.
“Integration and encapsulation is now complete, with ESA’s 2x satellites secured to Electron inside its nose cone and ready for launch,” Rocket Lab said in a post on X.
Both missions will depart from Launch Complex 1 located on New Zealand’s Mahia Peninsula.
Analyst Targets and Ratings
Wall Street sentiment toward RKLB leans optimistic, despite some variation among firms. The consensus recommendation currently stands at “Moderate Buy,” accompanied by an average price objective of $75.92 — marginally below Tuesday’s closing price.
Bank of America leads the bullish camp, having elevated its price target from $60 to $120 in January while maintaining a “Buy” recommendation on shares.
The broader analyst breakdown includes one Strong Buy, seven Buys, seven Holds, and one Sell. Zacks moved the stock from Strong Buy to Hold back in February, while TD Cowen has maintained its Buy rating.
The aerospace firm commands a market capitalization of $41.98 billion, features a conservative debt-to-equity ratio of 0.10, displays a quick ratio of 3.61, and maintains a current ratio of 4.08. The 200-day moving average rests at $63.25.
Insider Activity
Not all stakeholders are accumulating shares at current valuations. During the past three months, company insiders have liquidated approximately 1.85 million units totaling roughly $139 million.
SVP Arjun Kampani disposed of 23,711 units on March 4 at an average of $71.95 per share, decreasing his holdings by 5.62%. Insider Frank Klein similarly sold 36,768 units on the same date at identical pricing, reducing his ownership stake by 3.27%.
Despite recent selling pressure, company insiders retain 11.9% ownership. Institutional investors and hedge funds collectively control approximately 71.8%, with multiple smaller funds establishing new positions during Q4 of the prior year.
RKLB displays a trailing P/E ratio of -212.40 and a beta coefficient of 2.20, indicating elevated volatility characteristics. The 50-day moving average currently sits at $77.33.
